Skip to main content
Smart Investors Daily
AG

NYSE · AGTI

Agiliti, Inc.

Healthcare · Medical - Healthcare Information Services

$10.05

Down-$0.05 (-0.50%)

Updated Aug 16, 2026, 11:50 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.37B
P/E ratio
-69.66
Dividend yield
0.00%
52-week range
— – —
Volume
26.5M
Avg. volume
2.77M

Price performance

AGTI price history

1M range · 0 trading sessions · Daily adjusted prices

AGTI does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest AGTI news

The latest Smart Investors Daily articles mentioning AGTI.

AGTI research

Overview

Company profile and research snapshot.

Company profile

Agiliti, Inc., together with its subsidiaries, provides healthcare technology management and service solutions to the healthcare industry in the United States. It offers onsite managed services that are comprehensive programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity. The company also provides clinical engineering services comprising maintenance, repair, and remediation solutions for various types of medical equipment, including general biomedical equipment, diagnostic imaging equipment, and surgical equipment through supplemental and outsourced offerings. In addition, it offers equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. The company serves acute care hospitals, health systems and integrated delivery networks and alternate site providers Agiliti, Inc. was founded in 1939 and is headquartered in Eden Prairie, Minnesota.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$20.00
Implied upside
Analysts
AGTI recent ratings
DateFirmRatingTarget
Mar 26, 2024Raymond JamesMarket Perform
Mar 7, 2024UBSNeutral
Feb 6, 2024KeybancSector Weight
Jan 4, 2024Craig-HallumBuy
Nov 14, 2023Morgan StanleyUnderweight
Open full forecast

News briefing

No generated briefing is available yet.

businesswire.com · Sep 23, 2025

Agiliti Expands Oncology Offerings with Innovative Prostate Cancer Technologies and Services

MINNEAPOLIS--(BUSINESS WIRE)--Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, has expanded its oncology offerings to physicians and hospitals, providing greater value and access to focal therapy services for diagnosing and treating prostate cancer. “There are approximately 313,000 new prostate cancer cases every year in the U.S., and innovative technologies like HIFU and other focal therapies are an important component of modern care,” e.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.